Businessperson walks through brightly lit tunnel
·
3 Min Read

Why the nation needs clear advice on COVID-19 isolation

New CDC guidance for shorter isolation periods for those who test positive for COVID-19 are confusing and risk further virus spread.

Infectious Diseases
Four different types of face masks
·
6 Min Read

Clear up your patients’ confusion about which masks work best

The quick spreading COVID-19 Omicron variant has patients wondering what kind of mask to wear. Here’s what doctors can tell patients.

Infectious Diseases
UPDATED
·
2 Min Read

COVID-19 therapeutics and clinical information

Find clinical guidance on COVID-19 from the NIH, CDC, AMA and other health and medical research organizations.

Infectious Diseases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 3, 2022

In the news: CDC quarantine protocol, Pfizer booster for 12-15-year-olds, U.S. reports 1M+ new COVID infections, administration urged to adopt new pandemic strategy.

Publications & Newsletters
·
3 Min Read

Jan. 7, 2022: Advocacy Update spotlight on federal advocacy agenda for 2022

The AMA outlines its federal advocacy agenda for 2022. Learn more in this Advocacy Update spotlight.

Advocacy Update
·
8 Min Read

Jan. 7, 2022: National Advocacy Update

New physician toolkit PDF on No Surprises Act implementation and more in the latest National Advocacy Update.

Advocacy Update
·
2 Min Read

Jan. 7, 2022: Advocacy Update other news

New podcasts on surprise billing and telehealth available and more in the latest Advocacy Update other news.

Advocacy Update
Health professional applying an adhesive bandage to a patient's arm after giving a vaccination, both wearing masks
·
4 Min Read

COVID-19 treatments: What’s FDA authorized, and what works

More patients are turning up COVID-19 positive, thanks to the Omicron variant. Learn which outpatient therapies you can turn to for those at highest risk of severe outcomes.

Infectious Diseases
·
2 Min Read

AMA urges COVID-19 booster for newly eligible children and teens

AMA applauds the CDC and ACIP’s recommendation to expand use of a booster dose of the Pfizer-BioNTech COVID-19 vaccine to children and teens age 12 and older.

Press Releases